Shaimaa M. Mohammed, Afnan E. Abd-Almonuim, Ahmed Majeed, Haithm Khlaf
Shaimaa M. Mohammed1*, Afnan E. Abd-Almonuim2, Ahmed Majeed3, Haithm Khlaf4
1Ph.D. Clinical Chemistry, Al-Mustaqbal University College, Babylon, Iraq.
2Ph.D. Inorganic Chemistry, Al-Rasheed University College, Baghdad, Iraq.
3MSc. Pharmacology and toxicology, Al-Mustaqbal University College, Babylon, Iraq.
4MSc. Biochemistry, Faculty of Pharmacy, Al-Israa University, Amman, Jordan.
Volume - 14,
Issue - 10,
Year - 2021
The ethanol extract of Citrus maxima fruit peel was evaluated for its hypoglycaemic and hypolipidemic activity in normal and Streptozotocin (STZ)-induced diabetic rats, using fasting and glucose tolerance test measurements. Experiments were performed using Thirty-Two Male Wister albino rats randomly divided into 4 groups and each group have 8 animals. Group1 assigned as a control injected with normal saline only. Group 2 assigned as a diabetic control injected with Streptozotocin 50mg/Kg, Group 3 assigned for diabetic + Citrus maxima in a dose of 400mg/Kg, Group 4 is assigned for the diabetic + Citrus maxima in a dose of 600mg/Kg. The Streptozotocin is injected intraperitonially to all animal in the groups except the control group. Blood samples were collected from animal before and at 21th day end of the study period. Body weight, blood glucose, serum total cholesterol (TC), triglyceride (TG), and HDL cholesterol were analysed using diagnostic kits. Serum was separated from blood samples collected. In addition oral glucose tolerance test was performed in overnight fasted control animals. Results showed that Citrus maxima extract possesses significant antidiabetic activity against streptozotocin induced diabetic rats by decreasing blood glucose levels, maintaining body weight, and serum lipid concentrations to approximate normal level. Furthermore, the extract of the title plant possesses dose dependent antidiabetic activity.
Cite this article:
Shaimaa M. Mohammed, Afnan E. Abd-Almonuim, Ahmed Majeed, Haithm Khlaf. The Anti-Diabetic and Anti-Hyperlipidemia effect of Citrus maxima Fruit Peel extract in Streptozotocin - Induced Diabetic Rats. Research Journal of Pharmacy and Technology 2021; 14(10):5355-8. doi: 10.52711/0974-360X.2021.00934
Shaimaa M. Mohammed, Afnan E. Abd-Almonuim, Ahmed Majeed, Haithm Khlaf. The Anti-Diabetic and Anti-Hyperlipidemia effect of Citrus maxima Fruit Peel extract in Streptozotocin - Induced Diabetic Rats. Research Journal of Pharmacy and Technology 2021; 14(10):5355-8. doi: 10.52711/0974-360X.2021.00934 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-10-52
1. Dubey Nk, Rajesh Kumar, Parimila Tripathi, Global promotion of herbal medicines: India’s Opportunity, Current Science. 2004, 86 (1), 37-41.
2. Mabberley DJ. A classification for edible Citrus (Rutaceae). Telopea 1997; 7: 167-72.
3. Okwu DE. Citrus fruits: a rich source of phytochemicals and their roles in human health. Int J Chem Sci. 2008; 6(2): 451-471.
4. Uzun, A. and T. Yesiloglu (2012). Genetic Diversity in Citrus: Genetic Diversity in Plants, Caliskan, M. (Ed.). InTech publisher, 2012: 213-231.
5. Belitz HD, Grosch W. Fruits and fruit products. In: Hadziyev D, editor. Food chemistry. Berlin, Heidelberg: Springer Verlag; 1999. p. 748–99.
6. Sawalha SMS, Arra´ez-Roma´n D, Segura-Carretero A. Quantification of main phenolic compounds in sweet and bitter orange peel using CE–MS/MS. Food Chemistry 2009; 116: 567–74.
7. Gurib-Fakim A, Demarne F. Aromatic plants of Mauritius: volatile constituents of the leaf oils of Citrus aurantium L., Citrus paradisi Macfad. and Citrus sinensis (L.) Osbeck. J Essen Oil Res. 1995; 7(1): 65-69.
8. Y.C. Huo Et. Al., “Determination and comparison of naringin and naringenin contents among water extracts of various processed Citri grandis pericarpium.” Chinese Pharmaceutical Journal (Taipei) 1998 ; 50(3): 137-147.
9. Fidrianny I, Sari E, Ruslan K. Phytochemical content and antioxidant activities in different organs of pomelo (Citrus maxima [Burm.] Merr.) using 2,2‑diphenyl‑1‑picrylhydrazyl and phosphomolybdenum assay. Asian J Pharm Clin Res 2016; 9: 185‑90.
10. World Health Organization. Global atlas on cardiovascular disease prevention and control. Geneva: WHO; 2011.
11. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21 st century challenge. Lancet Diabetes Endo. (2014) 2: 56–64.
12. Derosa G, Maffioli P. Effects of thiazolidinediones and sulfonylureas in patients with diabetes. Diabetes Technol Ther. (2010) 12: 491–501.
13. B. A. Arias and L. Ramon-Laca, “Pharmacological properties of citrus and their ancient and medieval uses in the Mediterranean region,” Journal of Ethnopharmacology, Vol. 97, No. 2, Pp. 89–95, 2005.
14. Letouzey R. Identification of tropical woody plants in the absence of flowers and fruits; 1961.
15. Abeysinghe DC, Xian Li, Sun C, Zhang WS, Zhou CH, Chen SK. Bioactive compounds and antioxidant capacities in different edible tissues of Citrus fruit of four species. Food Chem 2007; 104: 1338‑44.
16. Trease GE, Evans WC. Textbook of Pharmacognosy. 16th ed. London Balliere‑Tindal; 2009.
17. Bhavana S, Santosh K, Satapathy N. Hypoglycemic and hypolipidemic effect of Aeglemarmelos leaf extract on STZ induced diabetic mice. Int J Pharmocol 2007; 3(6): 444-52.
18. Mangesh K., Vidyasagar G., Ashwini K. Antidiabetic potential of ethanolic extracts of Citrus maxima and Anvillea garcinii.Int. J Pharmaceutical innovations 2014; 4(1): 8-18.
19. Sacco F, Sean JH, Jurgen C, Marcel M, Anke S, Thomas K, Matthias S, Matthias M. Glucose-regulated and drug-perturbed phosphoproteome reveals molecular mechanisms controlling insulin secretion. Nature Communications. 2016; 7: 1-13.
20. Cerda J.J., Robbins F.L., Burgin C.W., Baumgatner T.G. and Rice R.W. The effects of grapefruit pectin on patients at risk for coronary heart disease without altering diet or lifestyle. Clin. Cardiol.1988, 11; 589-94.